当前位置: 首页 > 期刊 > 《中国药房》 > 2025年第15期
编号:2440087
脆性骨折术后规范化抗骨质疏松症药物治疗管理模式建立
http://www.100md.com 2025年9月2日 中国药房 2025年第15期
    

    中图分类号R969.3 文献标志码A 文章编号 1001-0408(2025)15-1926-05

    DOI 10.6039/j.issn.1001-0408.2025.15.19

    Establishment of a standardized management model for postoperative anti-osteoporosis medication in patientswith brittle fractures

    LIU Hao,YANG Yinglin,CAI Le,LI Shu, ZHU Man,CHEN Mengli(Dept. of Pharmacy,Medical SuppliesCenter,Chinese PLA General Hospital,Beijing10o853,China)

    ABSTRACTOBJECTIVETo investigate the establishment and promotionofanew standardized management model forantiosteoporosismedicationafterfragilityfracturesurgerybyresidentclinicalpharmacists,andprovidereferencesforresident pharmacists tocarryoutclinicalpharmaceuticalservices.METHODSFromJuly2023 toMarch 2024,595post-britefracture surgerypatientswereenrolled.UsingthePDCA(plan-do-check-act)cycle,residentcliicalpharmacistsidentifiedissuesand conductedinvestigationsinclinicalpractice.Throughintegratingclinicalpharmacistinterventionservicesbfore ......

您现在查看是摘要页,全文长 9630 字符